1. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole;Akova M.;Eur. J. Clin. Microbiol. Infect. Dis.,1991
2. Apport du laboratoire dans la surveillance du traitement antifongique par le fluconazole des candidoses chez les immunodeprimes;Blancard A.;Pathol. Biol.,1991
3. Comparison of vaginal flora after treatment with a clotrimazole 500-mg vaginal pessary or a fluconazole 150-mg capsule for vaginal candidosis;Boag F. C.;Genitourin. Med.,1991
4. Boyle F. T. J. F. Ryley and R. G. Wilson. 1987. In vitro-in vivo correlations with azole antifungals p. 31-41. In R. A. Fromtling (ed.) Recent trends in the discovery development and evaluation of antifungal agents. J. R. Prous Science Publishers S.A. Barcelona Spain.
5. Tablet sensitivity testing of pathogenic fungi;Casals J. B.;J. Clin. Pathol.,1979